Background illustration for clinical trials search

Paid Clinical Trials Irving

Discover 1,948 paid clinical trials in Irving, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study to Assess the Adverse Events, Change in Disease Activity, and How Oral ABBV-711 Tablets Move Through the Body as a Monotherapy and in Combination With Intravenously Infused Budigalimab (ABBV-181), in Adults With Advanced Squamous Tumors

for
Advanced Squamous Tumors
Location: Irving TX, Chicago IL, Grand Rapids MI, Huntersville NC,
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT07241039

Phase 1, Recruiting

A Study of JNJ-89862175 for Treatment of Advanced Solid Tumors

for
Advanced-stage Solid Tumors
Location: Irving TX, Orlando FL, Boston MA
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT07223125

Phase 1, Recruiting

Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors

for
Small Cell Lung Cancer Metastatic or Locally Advanced,
Location: Dallas TX, Houston TX, San Antonio TX, New Orleans LA,
Sponsor: SystImmune Inc.

Sex: All

Age: 18+

Code: NCT07080242

Phase 1, Recruiting

A Study to Investigate the Safety and Efficacy of KQB548 in Participants With Advanced Solid Malignancies

for
Solid Tumor Malignancies
Location: Irving TX, Austin TX, Houston TX, San Antonio TX,
Sponsor: Kumquat Biosciences Inc.

Sex: All

Age: 18+

Code: NCT07207707

Phase 1, Recruiting

A Phase I/II Study of CS2009 in Participants With Advanced Solid Tumors

for
Advanced Solid Tumors
Location: Irving TX, Los Angeles CA
Sponsor: CStone Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06741644

Phase 1, Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study to Learn More About How Safe BAY 3771249 is and How Well it Works in People With Advanced or Metastatic Colorectal Cancer That Has a KRAS G12D Mutation

for
Advanced/Metastatic Colorectal Adenocarcinoma
Location: Irving TX, San Antonio TX, Duarte CA
Sponsor: Bayer

Sex: All

Age: 18+

Code: NCT07535112

Phase 1, Recruiting

A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors

for
Cancer
Location: Dallas TX, Fort Worth TX, Austin TX, Houston TX,
Sponsor: IDEAYA Biosciences

Sex: All

Age: 18 - 70+

Code: NCT07540572

Phase 1, Recruiting

A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors

for
Gastric or Gastro-esophageal Junction (GEJ) Adenocarcinoma,
Location: Irving TX, Austin TX, Oklahoma City OK, Houston TX,
Sponsor: Astellas Pharma Global Development, Inc.

Sex: All

Age: 18+

Code: NCT07488676

Phase 1, Phase 2, Recruiting

A Study of HS-20110 in Participants With Advanced Solid Tumors

for
Solid Tumors
Location: Irving TX, Houston TX, San Antonio TX, Fort Wayne IN,
Sponsor: Hansoh BioMedical R&D Company

Sex: All

Age: 18+

Code: NCT06892379

Phase 1, Recruiting

A Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors (MK-3120-002)

for
Advanced Solid Tumors, Malignant Neoplasm
Location: Irving TX, Austin TX, Houston TX, Birmingham AL,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06818643

Phase 1, Phase 2, Recruiting

Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients

for
PDAC, PDAC - Pancreatic Ductal Adenocarcinoma, NSCLC,
Location: Irving TX, Houston TX, Omaha NE, Denver CO,
Sponsor: Tango Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06922591

Phase 1, Phase 2, Recruiting

AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors

for
Vulvar Adenocarcinoma, PDAC - Pancreatic Ductal Adenocarcinoma,
Location: Irving TX, Chicago IL, Scottsdale AZ, Grand Rapids MI,
Sponsor: Avacta Life Sciences Ltd

Sex: All

Age: 18+

Code: NCT07454642

Phase 1, Recruiting

A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma

for
Metastatic Castration Resistant Prostate Cancer (mCRPC),
Location: Irving TX, Oklahoma City OK, San Antonio TX, Omaha NE,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT03460977

Phase 1, Recruiting

A First-in-human, Phase I, Open-label, Multicenter Study of NM1F(Anti-PVRIG) in Patients With Advanced Solid Tumors

for
Ovarian Cancer, Melanoma, Triple Negative Breast Cancer,
Location: Dallas TX, Fairfax VA
Sponsor: Hefei TG ImmunoPharma Co., Ltd.

Sex: All

Age: 18+

Code: NCT05746897

Phase 1, Recruiting

FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC

for
Ovarian Cancer, Non-small Cell Lung Cancer
Location: Irving TX, Fort Worth TX, Oklahoma City OK,
Sponsor: Gilead Sciences

Sex: All

Age: 18+

Code: NCT06303505

Phase 1, Phase 2, Recruiting

Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TGW101 in Participants With Advanced Solid Tumors

for
Advanced Solid Tumors
Location: Irving TX, Houston TX, San Antonio TX, Scottsdale AZ,
Sponsor: Tagworks Pharmaceuticals BV

Sex: All

Age: 18+

Code: NCT06959706

Phase 1, Recruiting

BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors

for
Advanced Solid Tumor, Advanced Breast Cancer,
Location: Irving TX, Houston TX, San Antonio TX, Denver CO,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT06120283

Phase 1, Recruiting

A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors

for
MTAP-deleted Solid Tumors
Location: Irving TX, San Antonio TX, Nashville TN, Denver CO,
Sponsor: Bayer

Sex: All

Age: 18+

Code: NCT06914128

Phase 1, Phase 2, Recruiting

STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected Sarcomas

for
Solid Tumor, Sarcoma, Leiomyosarcoma,
Location: Irving TX, Houston TX, San Antonio TX, Grand Rapids MI,
Sponsor: STORM Therapeutics LTD

Sex: All

Age: 18+

Code: NCT06975293

Phase 1, Phase 2, Recruiting

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

for
Non-Small Cell Lung Cancer (NSCLC), Colorectal Cancer,
Location: Irving TX, Oklahoma City OK, Houston TX, San Antonio TX,
Sponsor: Revolution Medicines, Inc.

Sex: All

Age: 18+

Code: NCT06128551

Phase 1, Phase 2, Recruiting